Genentech Dodges FCA Claims Over Avastin's Side Effects
By Daniel Langhorne · October 29, 2015, 11:55 PM EDT
A New Jersey federal judge on Thursday dismissed a False Claims Act against Genentech Inc. regarding its cancer drug Avastin, holding a whistleblower didn't show the drug's advertised claims were false...
To view the full article, register now.